Analysen von Benjamin Jackson
| 28.05.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 07.05.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 30.04.25 | GSK Hold | Jefferies & Company Inc. | |
| 29.04.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.04.25 | Novartis Hold | Jefferies & Company Inc. | |
| 24.04.25 | Roche Hold | Jefferies & Company Inc. | |
| 17.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 13.03.25 | Roche Hold | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 12.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 10.03.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 15.11.24 | EVOTEC Hold | Jefferies & Company Inc. | |
| 13.11.24 | EVOTEC Hold | Jefferies & Company Inc. | |
| 06.11.24 | EVOTEC Hold | Jefferies & Company Inc. | |
| 07.10.24 | EVOTEC Hold | Jefferies & Company Inc. | |
| 14.08.24 | EVOTEC Buy | Jefferies & Company Inc. | |
| 07.08.24 | EVOTEC Buy | Jefferies & Company Inc. | |
| 19.07.24 | EVOTEC Buy | Jefferies & Company Inc. | |
| 22.05.24 | EVOTEC Buy | Jefferies & Company Inc. | |
| 20.05.24 | EVOTEC Buy | Jefferies & Company Inc. | |
| 24.04.24 | EVOTEC Buy | Jefferies & Company Inc. | |
| 28.03.24 | EVOTEC Buy | Jefferies & Company Inc. | |